Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 9c
Tweet Send to a FriendGet Alerts LGND Hot Sheet
Price: $27.47 -1.72%
Revenue Growth %: +108.9%
Financial Fact:
Interest expense: -912K
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: +108.9%
Financial Fact:
Interest expense: -912K
Today's EPS Names:
ANF, DXLG, FL, More
Trade LGND Now!
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q1 EPS of $0.07, $0.09 better than the analyst estimate of ($0.02). Loss from continuing ops was ($0.03). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $8.02 million.
Ligand Pharmaceuticals, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Ligand Pharmaceuticals, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- UPDATE: Intuit, Inc. (INTU) Tops Q3 EPS by 4c, Offers Guidance
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
